F/m Emerald Life Sciences Innovation ETF LFSC

Full chart Compare
Set alert

Price alert · LFSC

All alert types
44.19 USD +0.99 (+2.29%)

At closeNov 3, 2026, 4:00 PM EST

44.19 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

44.05 Day range 44.54
31.02 52-week range 48.78
YTD
+20.67%
1 year
+36.86%

F/M Emerald Life Sciences Innovation ETF

Issuer
Emerald
Asset class
Equity
Expense ratio
0.79%
Assets under management
$122.00M
NAV
43.63
Holdings
0
Inception
2024-10-30
Top 10 weight
55.68%

Top holdings

  1. REPL Replimune Group Inc 10.06%
  2. LIVN LivaNova PLC 7.03%
  3. COGT Cogent Biosciences Inc 5.82%
  4. TVTX Travere Therapeutics Inc 5.75%
  5. GH Guardant Health Inc 5.36%
  6. BLLN Billiontoone Inc 4.97%
  7. CORT Corcept Therapeutics Inc 4.62%
  8. SYRE Spyre Therapeutics Inc 4.10%
  9. MANE VeraDermics Inc 3.99%
  10. UTHR United Therapeutics Corp 3.99%
  11. MIRM Mirum Pharmaceuticals Inc 3.54%
  12. CYTK Cytokinetics Inc 3.24%
  13. TMDX TransMedics Group Inc 2.78%
  14. ICUI ICU Medical Inc 2.75%
  15. SVRA Savara Inc 2.67%
  16. AXSM Axsome Therapeutics Inc 2.60%
  17. TRVI Trevi Therapeutics Inc 2.25%
  18. PVLA Palvella Therapeutics Inc 2.19%
  19. CBLL Ceribell Inc 2.06%
  20. TWST Twist Bioscience Corp 1.99%
  21. PRAX Praxis Precision Medicines Inc 1.89%
  22. NKTR Nektar Therapeutics 1.63%
  23. VRDN Viridian Therapeutics Inc 1.62%
  24. DNTH Dianthus Therapeutics Inc 1.55%
  25. CRVS Corvus Pharmaceuticals Inc 1.39%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 100.00%

Updated 2026-11-03

Held by funds

1 US ETFs and mutual funds hold LFSC · largest positions

Funds holding LFSC, by value held
FundValue heldWeight in fund
NMBL $840.81K3.56%

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Financial Investors Tr-Emerald Growth Fund92.29%2,000,00047.48MOct 30, 2024